Enantiomerically pure chiral amines are highly valuable functionalized molecules with a wide range of applications including (i) intermediates for the synthesis of pharmaceutical and agrochemical active ingredients, (ii) resolving agents for the separation of enantiomers via diastereomeric salt formation, and (iii) ligands for asymmetric synthesis using either transition metal catalysis or organocatalysis [1]. The option of preparing chiral amines using biocatalytic approaches is now viewed as attractive as a result of recent developments in biocatalyst availability, methods for improving biocatalyst stability, and the inherent high selectivity and catalytic activity that can be obtained through enzyme catalysis. This chapter reviews the methods that are currently available for the preparation of chiral amines using biocatalysis. The review focuses on those biocatalytic methods in which the amine functionality is involved directly in the biocatalytic transformation (e.g., the synthesis of amino alcohols in which the alcohol functionality is manipulated by lipase-catalyzed acylation or hydrolysis are omitted). In addition, biocatalytic methods for the preparation of amino acids are also outside the scope of this review. The chapter is organized according to the three general approaches that have been developed, namely, kinetic resolution (KR), dynamic kinetic resolution (DKR) and deracemization, and finally asymmetric synthesis. A final section deals with emerging approaches including the use of imine reductases. As summarized in Figure 14.1, using a-methylbenzylamine 1 as a model compound, each of the methods discussed in this chapter possesses advantages and disadvantages in terms of (i) availability of starting material, (ii) efficiency of the process (i.e., kinetic resolution versus asymmetric synthesis), (iii) range of chiral amines that can be prepared (1 , 2 , 3 ), (iv) availability of biocatalyst, and (v) possible requirement for cofactor recycling. Each of these issues is dealt with throughout the chapter. Table 14.1 provides details of commercial sources of the enzymes referred to in the text.